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Abstract
Background: Engagement of the antigen receptor on immature B-lymphocytes leads to cell cycle arrest, and
subsequent apoptosis. This is an essential process for eliminating self reactive B cells during its different stages of
development. However, the mechanism by which it is achieved is not completely understood.
Results: Here we employed a systems biology approach that combined extensive experimentation with in silico
methodologies to chart the network of receptor-activated pathways that mediated the arrest of immature B cells
in the G1 phase of the cell cycle. Interestingly, we found that only a sparse network of signaling intermediates was
recruited upon engagement of the antigen receptor. This then led to the activation of a restricted subset of
transcription factors, with the consequent induction of genes primarily involved in the cell death pathway.
Subsequent experiments revealed that the weak initiation of intracellular signaling pathways derived from
desensitization of the receptor-proximal protein tyrosine kinase Lyn, to receptor-dependent activation. Intriguingly,
the desensitization was a result of the constitutive activation of this kinase in unstimulated cells, which was likely
maintained through a regulatory feedback loop involving the p38 MAP kinase. The high basal activity then
attenuated the ability of the antigen receptor to recruit Lyn, and thereby also the downstream signaling
intermediates. Finally, integration of these results into a mathematical model provided further substantiation to the
novel finding that the ground state of the intracellular signaling machinery constitutes an important determinant
of the outcome of receptor-induced cellular responses.
Conclusions: Our results identify the global events leading to the G1 arrest and subsequent apoptosis in immature
B cells upon receptor activation.
Background
Cellular responses to environmental cues are mediated
through activation of the signal transduction machinery.
This machinery is best represented as a complex net-
work that, in turn, governs the decision-making capabil-
ities of the cell [1,2]. Engagement of a cell surface
receptor induces activation of signal transduction cas-
cades that involve a series of phosphorylation/depho-
sphorylation events. These phosphorylation-dependent
signaling events eventually transduce signal to
transcription factors (TFs), with the latter then modulat-
ing expression levels of the downstream genes [3]. The
cellular response thus elicited is a consequence of this
alteration in the gene expression profile. Information
processing is an integral part of signal transmission
wherein calibration of both quantitative and qualitative
features of the signal is facilitated by the many regula-
tory elements, or motifs, that are distributed across the
signal transduction and transcription regulatory net-
works [4]. These regulatory elements constitute emer-
gent features of the corresponding networks and they
play a critical role in ensuring that the cellular phenoty-
pic response is contextually derived from the nature of
the inducing stimulus [5].
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Several studies have at least partially delineated the
emergent features of the signaling network that are gen-
erated in response to engagement of a variety of cell
surface receptors [6-8]. Similarly, topological alterations
in the transcription regulatory network that are gener-
ated under specific conditions of cell activation have
also been mapped [9]. However, a more global perspec-
tive that rationalizes how these two networks integrate
to ensure context-specificity of the cellular response is
presently lacking. An understanding at this level, how-
ever, is critical for eventual resolution of the mechan-
isms that underlie cell fate decisions, as well as those
that lead to aberrations in cellular behavior [10].
In the present study we adopted a systems biology
approach to address this question. For this we took the
murine B-lymphoma cell line CH1 as the model system.
These cells are a prototype of the transitional stage of
immature B cells and previous studies have shown that
stimulation of these cells through the B-cell antigen
receptor (BCR) leads to late G1 arrest, which is then fol-
lowed by apoptosis [11,12]. This response to BCR acti-
vation is also reminiscent of that seen for immature B
cells in vivo, and contributes towards the elimination of
self-reactive cells from the peripheral B-cell repertoire
[13]. It was therefore of interest to delineate the regula-
tory network involved in transmission of receptor-
activated signals, to eventually enforce the cell cycle
arrest response.
A combination of experimental with in silico
approaches enabled us to map the network of pathways
emanating from the BCR, and leading up to the induc-
tion of genes responsible for the G1 arrest. A detailed
analysis of the time-dependent phosphorylation of sev-
eral signaling intermediates revealed that BCR-engage-
ment resulted in only a partial and transient activation
of the signaling network. A direct consequence of this
was a weak perturbation of the transcription regulatory
network, which in turn led to the expression of only
those genes that were involved in the cell death path-
way. These latter findings were facilitated through a
large-scale survey of TFs for their sensitivities to BCR-
activation, and by a microarray analysis of the gene
expression profile in stimulated cells followed by experi-
mental verification of the functional roles of the early
induced genes. Interestingly, our subsequent experi-
ments revealed that integration between the signaling
and the transcription regulatory networks was controlled
by the MAP kinase signaling intermediate p38. This
control was enforced through a receptor-associated
phosphatase and involved the feedback regulation of
Lyn, the kinase that initiates signaling from the BCR. It
was this feedback control exercised at the level of signal
initiation that then eventually resulted in the expression
of genes causing cell cycle arrest. An incorporation of
these observations into a mathematical model provided
further insights into how changes in the basal activation
state of the early intermediates defines sensitivity of the
signaling machinery to a given cell surface receptor.
Thus, our studies also reveal the etiology of cell type-
specific responses to a given stimulus.
Methods
Cell Culture, Stimulation and detection of
phosphoproteins
The experimental conditions employed in this study
were first established in standardization experiments
involving both different doses of anti-IgM, and varia-
tions in the stimulation times. A saturating effect on G1
arrest of CH1 cells was seen at an anti-IgM concentra-
tion of between 3-5 μg/ml, with no additional effect also
when the stimulation time was extended beyond 1 h.
Consequently, stimulation of CH1 cells for 1 h with a
final anti-IgM concentration of 5 μg/ml was taken as
the optimal condition for our study. Consequently, CH1
cells were maintained at a density of 0.5 x106 cells/ml in
RPMI 1640 supplemented with 10% fetal calf serum and
1X penicillin/streptomycin. They were stimulated with
the F(ab)2 fragment of rabbit anti-mouse IgM (5 μg/ml)
in RPMI for a period of up to 1 hr. At appropriate
times thereafter, aliquots of cells were collected, centri-
fuged, and the cell pellets stored in liquid nitrogen. Just
prior to electrophoresis, cells were lysed in lysis buffer
(20 mM HEPES, 10 mM NaCl, 1.5 nM MgCl2, 0.2 mM
EDTA, 0.5% Triton X-100, 0.5 mM DTT, 1 mM sodium
orthovanadate, 1 mM NaF, and a cocktail of protease
inhibitors) followed by removal of the nuclear material
and other debris through centrifugation. The detergent-
soluble proteins were then resolved by SDS-PAGE. Spe-
cific proteins and phosphoproteins (all phospho-specific
antibodies, as described in Additional File 1: Supplemen-
tal Table S6, were from Cell Signaling Technologies)
were detected by Western blot using appropriate antibo-
dies. For this, lysates were resolved by SDS-PAGE and
then transferred to a nitrocellulose membrane (Hybond
ECL; Amersham Biosciences). The membrane was incu-
bated in odyssey blocking buffer for 2 h with gentle
shaking at 37°C. The blocking buffer was replaced with
an appropriate dilution of primary antibody in odyssey
buffer with 10% PBS and incubation was continued at 4°
C over night with gentle shaking. Thereafter, the blots
were washed thrice with PBST for 5 min each. After
washing, the blots were incubated with infrared dye
labeled secondary antibodies (1:15,000 dilutions,
obtained from Licor Inc, USA) at 37°C for 2 h. Blots
were scanned using Odyssey scanner using an 800 nm
laser, and band intensities were determined by using
Odyssey software. Minimum intensity surrounding the
bands on the film was taken as its background and
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subtracted to give the true intensity. All blots were re-
probed for GAPDH as loading controls. Intensities were
normalized against the intensities of GAPDH molecule.
Co-Immunoprecipitation and Western blot analysis
Lysates were prepared from between 2-5 × 107 cells in a
buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
and a phosphatase inhibitor cocktail (Roche, Mannheim,
Germany). The clarified supernatant was quantified for
protein concentration by the Bradford assay (Bio-Rad
Laboratories). For immunoprecipitation, 1 mg of total
protein in 500 μl of lysis buffer was incubated with 20
μl of Sepharose 4B (Amersham) for 1 h at 4°C. The pre-
cleared lysate was then incubated with 2 μg of the anti-
body overnight at 4°C, followed by 20 μl of protein
A-agarose beads for 2 h at 4°C. After five washings in
lysis buffer, the beads were boiled in Laemmli buffer,
and the proteins were separated by SDS-PAGE. Further
steps for Western blot analyses were as described above.
In-vitro Phosphatase Assay
This was done essentially as described earlier, using
para-nitrophenyl phosphate as the substrate [14]. That
comparable amounts of the phosphatase SHP-1 were
present in samples from the individual groups was again
ensured through Western blot analyses on parallel sets
of immunoprecipitates.
Cell cycle analysis by flow cytometry
Cells were plated in the wells of a 96-well plate and sti-
mulated with anti-IgM for 1 h after which the cells were
washed and replaced with fresh medium without anti-
IgM. At 16 h after initiation of stimulation, the cells
were harvested and stained with propidium iodide for
analysis by flow cytometry. The extent of cell cycle
arrest was determined by measuring the relative propor-
tion of cells in the G0/G1, versus the S and G2/M
phases in each of the experimental groups.
siRNA-mediated suppression of BCR-induced genes
All the specific siRNAs were procured from Qiagen.
HiPerfect (Qiagen) was used for transfection of cells
with the siRNAs (at a final concentration of 100 nM)
strictly following the protocol supplied by the manufac-
turer. In initial standardization experiments, the silen-
cing obtained was between 70 and 95% at 48 h after
transfection, as detected by RT-PCR. The list of catalog
numbers and source of siRNAs used is provided in
Additional File 1: Supplemental Table S5. For all of the
experiments described here, a parallel control set was
always included wherein cells were treated with siRNA
specific for GFP (mock siRNA-treatment). After 48 hr
of siRNA transfection cells were stimulated for 1 h and
at the16 h time point they were harvested and stained
with propidium iodide for acquisition and subsequent
cell cycle analysis (Additional File 1: Supplemental Fig.
S2). In experiments involving the use of specific inhibi-
tors, these inhibitors were added to cells at 30 min prior
to stimulation. At the end of the 1 h stimulation period
with anti-IgM, however, these inhibitors were also
washed out and no fresh inhibitor was added for the
remainder of the experiment.
RNA Isolation and Realtime-PCR
Total RNA was isolated with TRIzol (Invitrogen) and
digested with RNase free DNase I prior to the reverse
transcription reaction. Estimation of relative transcript
levels by real time PCR was obtained as a commercial
service from Labindia Life Sciences (Gurgaon, India).
The assay and analysis were performed as previously
described [15]. Also refer additional file 1 for detailed
methods.
Confocal Microscopy
Staining Protocol
Staining was performed as described [16]. To examine
co-localization between p38 and SHP-1, CH1 cells (0.7
million) seeded on glass coverslip coated with CellTak
(BD Bioscience) were stimulated with anti-IgM for
5’min. Cells were fixed with 3% paraformaldehyde in
PBS for 10 min at room temperature followed by
quenching with 50 mM ammonium chloride for 10 min.
Fixed cells were permeabilized by incubating with 0.2%
Triton X-100 in PBS for 5 minutes followed by blocking
(3% bovine serum albumin and 0.5% Tween20 in PBS)
for 2 hours. Cells were incubated for 1-hour with
respective primary antibodies (p38 and SHP-1 raised in
mouse and rabbit respectively and diluted 1:100 with
blocking buffer). This was followed by three washes
with PBST and incubation with respective secondary
antibodies (Alexa-Fluor 488 and Alexa-Flour 568 conju-
gated to anti-rabbit and anti-mouse IgG (Molecular
Probes)). All cover slips were mounted on slides with
Antifade (Biorad).
Image Capturing
Stained cells were observed with a Nikon TE 2000E
laser scanning confocal microscope equipped with 60X/
1.4 NA planapochromat DIC objective lens. Alexa Flour
488 and 568 were excited at 488 and 568 nm with an
argon ion and He-Neon laser respectively. The emis-
sions were recorded through emission filter set 515/30;
605/75. Serial confocal sections (0.5 μm thick) within a
z-stack spanning a total thickness of 10-12 μm were
taken in individual green and red channels using the
motor drive focusing system. Images were acquired,
with a scanning mode format of 512 × 512 pixels. The
transmission and detector gains were set to achieve best
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signal to noise ratios and the laser powers were tuned to
limit bleaching of fluorescence. The refractive index of
the immersion oil used was 1.515 (Nikon). All settings
were rigorously maintained for all experiments.
Image Analysis
All images were quantified using Image-Pro® Plus ver-
sion 6.0, a commercially available software package from
Media Cybernetics.
The merged confocal images were subjected to co-
localization analysis to determine the “Pearson Coeffi-
cient” proposed by [17].
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Where S1i is signal intensity of the ith pixels in chan-
nel 1; S1avg is the average intensity of all pixels in chan-
nel 1; S2i is signal intensity of the ith pixels in channel
2; S2avg is the average intensity of all pixels in channel 2.
About 50 cells were analyzed in 3 sets of slides for the
co-localization studies. All the images are in the Tiff
RGB 24 format. To reduce the unwanted background
noise generated by the photomultiplier signal amplifica-
tion, all the image stacks were treated with two-
dimensional filters (Gaussian and sharpening filtering).
Protein/DNA arrays
Aliquots of either unstimulated cells, or cells stimulated
with anti-IgM for the indicated times, were collected,
centrifuged, and nuclear extracts were prepared as pre-
scribed by the manufacturer. 10 μg of each nuclear
extract was separately incubated with the biotinylated
probe mix from the array kit for 30 min at 15°C. This
mix contains oligonucleotides representing the consensus
binding sites for 345 TFs. At the end of this incubation
period, probes bound to transcription factors present in
the nuclear extract were isolated by column chromato-
graphy, and these bound probes were then dissociated
from the respective transcription factors by using the
protocol recommended by the manufacturer. These sam-
ples were then hybridized (42°C for 16 h) with the
Panomics Protein-DNA Spin Combo Array Kit (catalog
number MA1215, http://www.panomics.com/index.php?
id=product_18#product_listings_18) membranes, which
contains an array of oligonucleotide sequences that are
complementary to those of the TF binding sites in the
probe mix (A complete list of target Cis-regulatory ele-
ments present in the array, their description and the cor-
responding references are provided by the manufacturer
at http://www.panomics.com/index.php?id=product_18).
The array was then washed, blocked, incubated with
Steptavidin-HRP, and visualized by enhanced chemilumi-
nesence. The blot was imaged using a PhosphoImager
(Typhhoon 9210, GE Healthcare) and spot intensities
were quantified using Imagequant TL. The quantified
spots values were normalized against the average value of
all the controls spotted on the border of membrane.
Array experiment results from samples that were stimu-
lated with anti-IgM were directly compared to the unsti-
mulated control blot and spots that had increased by
greater than 2-fold in the stimulation experiments were
scored as positive for activation. All transcription factor
array experiments were done in duplicate and only those
TFs that were activated in both experiments were scored
as positive for activation. Values for individual spot inten-
sities are provided in Additional File 1: Supplemental
Table S1, whereas the raw images of the blots are shown
in Additional File 1: Supplemental Fig. S3
Identification of overrepresented Transcription Factor
binding site for the set of early induced genes
The TRANSFAC® database was used for our analysis
and the commercial license for the same was obtained
from BIOBASE. We employed the MATCH algorithm
to identify the overrepresented transcription factor bind-
ing site in our gene of interests. TFBS was scanned for
1000 bp upstream and 500 bp downstream for the gene
of interest. The gene sequence was for mouse was
downloaded from Genome browser http://genome.
ucsc.edu/cgi-bin/hgGateway?hgsid=145319238&clade=
mammal&org=Mouse&db=mm8.
Results
BCR-dependent signaling arrests cycling of CH1 cells
The murine B lymphoma CH1 cells express surface
antigen receptors (BCR) of the IgM class. Transient sti-
mulation of cell through these receptors with anti-IgM
antibodies for 1 h resulted in an arrest of these cells in
the G1 phase of the cell cycle. This arrest could be
detected at 16 hr, with consequent apoptosis of the cells
at the later time points (Figure 1A). Further, as expected
[18], this G1 phase arrest was also characterized by an
increase in intracellular levels of the p27 protein (Figure
1A). This protein inhibits the cell cycle-regulatory
kinases CDK4/6 and CDK2 in a stoichiometric manner,
thereby attenuating their ability to promote G1 to S
phase transition [18]. Thus CH1 cells mimic primary
immature B cells insofar as their response to BCR cross-
linking and, therefore, provide a good model for study-
ing antigen-induced clonal deletion of transitional stage
B-lymphocytes [19].
We next examined the early signaling events activated
by this receptor. For this cells were stimulated with
anti-IgM and the time-dependent phosphorylation pro-
files of a panel of twenty signaling intermediates were
examined by Western blot analyses. These signaling
intermediates were selected on the basis that they col-
lectively represented a diverse set of known canonical
signaling pathways (References mentioned in Additional
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Figure 1 Anti-IgM-dependent stimulation of CH1 cells leads to a poor activation of the signaling responses and induces cell cycle
arrest. Panel A shows the histograms representing the distribution of cells in each phase of the cell cycle observed by FACS analysis performed
16 hours after a 1 h stimulation of CH1 cells with anti-IgM. An arrest in cell cycle is clearly evident here, with a greater than 2-fold increase in
the G1 phase population. Also shown in the inset is the result of a Western blot analysis revealing accumulation of p27 upon anti-IgM
stimulation over the course of time. Panel B depicts the activation profiles of fourteen signaling intermediates probed by Western blots (see text
for details and Additional File 1: Supplemental Fig. S1A) after anti-IgM stimulation. The plot represents mean value of quantified, normalized fold
change in phosphorylation of the signaling intermediates in a time dependant manner obtained from three individual replicates and the over all
S.D observed was < 10%. Also refer Additional File 1: Supplemental Fig. S1B for a detailed plot of the figure. An Ingenuity Pathway Analysis (IPA)
of the set of early induced genes upon anti-IgM stimulation of CH1 cells is shown in Panel C. This network depicts the core module identified
by IPA based on the list of early-induced genes used as the seed nodes. Here, the nodes in red represent the over-expressed genes while those
in green are those whose expression was found to suppressed (Detailed key in Additional file 1). The canonical pathways identified by IPA for
the set of early induced genes in CH1 cells and their corresponding significant levels of contribution by the early induced genes is shown in
Panel D.
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File 1: Supplemental Table S1). However, of the twenty
molecules examined, we could observe BCR-dependent
phosphorylation for only fourteen intermediates, with
no significant effects being evident for the remaining six
molecules (Data not shown). The remaining fourteen
molecules were phosphorylated in a time-dependent
manner by anti-IgM, although the individual profiles
varied significantly (Additional File 1: Supplemental Fig.
S1). This is evident from the quantified representations
shown in Figure 1B. Thus stimulation of cells with anti-
IgM resulted in vigorous phosphorylation of the mem-
bers of the MAP kinase (MAPK) family ERK-1/2 (ERK)
and JNK and, to a slightly lesser extent, also Raf-1 and
MEK-1/2 (MEK) (Figure 1B). BCR-dependent phosphor-
ylation, but with distinct kinetics and amplitude was
also observed for Akt, PKCδ, p38, Lyn, and CaMKII
(Figure 1B). Particularly surprisingly, however, was that
stimulation elicited only a nominal phosphorylation
response from the remaining intermediates, with mole-
cules such as Syk, Bad, Gsk3b, PLCg PKCδ and PKA
achieving peak levels that were less than 2-fold above
their respective basal values (Figure 1B). Thus, even this
limited examination of a small panel of signaling inter-
mediates highlights the sparse character of the BCR sig-
naling network - with only a few signaling pathways
being activated - in CH1 cells.
BCR-dependent stimulation of CH1 cells induces the
expression of cell cycle regulatory genes
We had previously examined induction of the early
response genes in CH1 cells following stimulation with
anti-IgM for 1 h [20]. A microarray analysis had identi-
fied that 19 genes were reproducibly upregulated to
levels that were >2-fold above their basal value, whereas
four genes were significantly downregulated [20](Acces-
sion No. E-MTAB-82). An Ingenuity Pathway Analysis
using these twenty-three genes as the seed nodes yielded
a top network, containing activities related to cell death
and cancer, that incorporated 14 of these genes (11
upregulated and 3 downregulated) (Figure 1C). The
canonical pathways affected by the nodes of this net-
work are shown in Figure 1D. It is interesting to note
that, in addition to the p38 pathway, the prominent
pathways identified here were those that induced either
cell death (death receptor signaling, apoptosis signaling),
or anti-proliferative responses (IL-10 signaling, PPAR
signaling, IL-6 signaling). For the sake of simplicity how-
ever we subsequently concentrated on only those eleven
genes from this subset, whose expression levels were
upregulated on stimulation of cells with anti-IgM (Fig-
ure 1C). The cellular functions attributed to the pro-
ducts of these genes include regulation of cell
proliferation (ZFP36, CD69), regulation/repression of
transcription (DDIT3, ATF3, EGR1, FOSB), inhibition of
signal transduction (RGS1), and regulation of apoptosis/
cell death (AXUD1, TNF).
BCR-dependent regulation of transcription factor
activities
The modulation of gene expression effected by signals
emanating from a cell surface receptor is mediated
through the regulation of transcription factor activities.
Therefore, we next probed for the effects of anti-IgM
stimulation on the activation of transcription factors
(TFs). For these experiments we employed a commercial
array in which oligonucleotides corresponding to the
binding sites of 345 transcription factors were spotted.
This array, therefore, enabled us to simultaneously assay
the activation of a large subset of TFs.
Given that 1 h stimulation was sufficient to eventually
induce G1 arrest, we measured the extent of TF activa-
tion in cells that were stimulated with anti-IgM for either
20 or 40 min and the representative blots thus obtained
are shown in Figure 2A. A quantitative analysis of the
intensities of the spots for each TF under the various
conditions then yielded an anti-IgM-specific activation
profile for the individual TFs. For our analysis, however,
we only considered those TFs that were affected by >2-
fold from their basal value to be either activated or inacti-
vated in a BCR-dependent manner. Consistent with rela-
tively poor activation of the signaling machinery
observed earlier, anti-IgM-mediated stimulation also
resulted in a weak perturbation of the TF network. Thus,
of the 345 TFs examined activities of 279 remained unaf-
fected, whereas that of 30 was suppressed. Further,
although the remaining 36 TFs were activated by anti-
IgM they - however - showed delayed kinetics with
activation being detected only at 40 min of stimulation,
(Figure 2B). Examples of these included NFKB1, FOSL1,
PTFB1, NF1, and TRP53. In contrast, TF inactivation was
relatively more rapid and was detectable by 20 min of sti-
mulation in most cases. Examples of this latter group
were GATA4, PAX6, Sp1, EP300, CMYB, NFATC2, and
MZF1 (Figure 2B). The list of molecules shown in Figure
2B along with their corresponding Human Entrez Gene
IDs is given in Additional File 2.
The activation profiles for a representative subset of the
transcription factors probed here could be independently
verified in Western blot experiments that monitored their
increase in the nuclear compartment (Additional File 1:
Supplemental Fig. S3B). However, there were some minor
differences that could be observed in the TF activation
pattern in the case of p-p53 and cMyc (Additional File 1:
Supplemental Fig. S3B). Overall this validation supports
that the results in Figure 2 indeed identify the BCR-sensi-
tive TFs in CH1 cells. Further, at least some of these TFs
may be expected to be involved in driving the arrest of
actively cycling cells in the G1 phase.
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Defining the key transcriptional regulators that enforce
the cellular response
Our cumulative experiments so far helped to describe at
least some of the signaling events activated by the BCR,
as well as their downstream effects on TF activation,
and the consequent gene expression. It was, therefore,
of interest to synthesize these data to generate a more
integrated perspective on the BCR-regulated arrest of
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Figure 2 BCR-dependent modulation of TF activities. Panel A shows the representative arrays of transcription factor activation in CH1 cells in
response to anti-IgM. Cells were stimulated with anti-IgM and the activation profiles of transcription factors probed by TF array either in
unstimulated cells, or in cells stimulated for either 20 or 40 min with anti-IgM. Where, the unstimulated cells were treated as control. Plot in the
panel B shows the quantified changes observed in the TF activity upon stimulation of CH1 cells with anti-IgM. Only the subset of TFs that
showed >2 fold activation or repression in activity in either of the time points were plotted in log10 scale after. The nomenclature used to
denote the TFs are the aliases provided by the array manufacturer, their corresponding Entrez Gene IDs are listed in Additional File 2.
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cycling CH1 cells. To do this we combined our experi-
mental results with an in silico approach as illustrated in
Figure 3A. Our goal here was to extract the regulatory
network that could be implicated in this process.
As the first step, we sought to identify those TFs that
could be involved in regulating the set of early-induced
genes described in Figure 1C. For this we employed the
MATCH software to scan for TF binding sites that were
over-represented in the promoter regions (i.e. from
-1000 nt to +500 nt relative to the transcription start
site) of each of the eleven early-induced genes. In addi-
tion, we also surveyed the literature for TFs that have
been experimentally demonstrated to regulate expres-
sion of these target genes. Results from both approaches
were then combined to yield a list of sixteen TFs for
these eleven genes (see Additional File 1: Supplemental
Table S4). From this list we next selected those TFs that
were also either activated or suppressed by anti-IgM in
Figure 2. This exercise resulted in the further short-list-
ing of seven of these TFs. Importantly, the identification
of several of these was also supported by experimental
evidence in the literature demonstrating their roles in
regulating expression of at least some of the target
genes (Additional File 1: Supplemental Table S4). Link-
ing these seven TFs to the target genes then yielded a
dense overlapping regulatory (DOR) network as shown
in Figure 3B. Such a DOR network represents a typical
regulatory module that is expected for the regulation of
multiple genes by a common set of TFs [21,22].
Of the seven TFs described in Figure 3B, TBP,
NFKB1, TRP53, and FOSL1 were all activated upon sti-
mulation of cells with anti-IgM (Figure 2). Of these TBP
is a component of the general transcription factor
TFIID [23], while both NFKB1 and TRP53 are known
regulators of gene expression [24-28]. Finally, FOSL1 is
an oncogene product with a role in tumor formation
[29]. Activity of the remaining three TFs - MZF1, Sp1,
and NFATc2 - was, however, suppressed in response to
BCR stimulation. Here MZF1 is known for its regulation
of apoptosis [30], whereas NAFTc2 and Sp1 can both
act as repressors of gene expression in specific instances
[31,32]. Thus the BCR-dependent activation profile of
these seven TFs appears to be consistent with the
induced expression of the early response genes through
the links described in Figure 3B.
Construction of an in silico network that links BCR-
signaling to gene expression
To extract the network of pathways linking BCR acti-
vation to the cellular response, we first merged the
BIND[33], DIP [34], IntAct [35], MINT [36], Human
Protein Reference Database [37] and Protein-Protein
interaction database [38] PPI databases to generate a
compilation of all known reported PPIs. Eliminating
those interactions that lacked experimental support
from at least two independent studies then refined the
resulting network. This resulted in a core undirected
network of about 4300 nodes and 10700 edges. Here
the CD79a and CD79b subunits associated with the
BCR [39] were taken together and considered as a sin-
gle BCR complex.
Shortest path analysis of networks is generally consid-
ered to represent a reliable method for capturing infor-
mation on the transduction of signals through the
various intermediate nodes [40]. Further, our experi-
ments in Figure 1B had also helped to distinguish at
least some of the signaling intermediates that were
either significantly activated, or ignored, upon BCR sti-
mulation of cells. Therefore, starting from the BCR, we
next traced all the possible shortest paths leading to
each human ortholog of the signaling intermediate that
was shown to be activated in Figure 1B. Here, we con-
sidered a signaling intermediate to be activated only if
its phosphorylation levels were increased by at least 2-
fold in response to anti-IgM stimulation. This filtration
exercise short-listed Raf1, ERK-1/2, MEK-1/2, p38, JNK,
CAMKII, Lyn and Akt1 as the target nodes, and all the
resulting shortest paths originating from the BCR to
each of these intermediates were merged to create a
sub-network.
In order to complete the above network we again
employed the shortest path algorithm to next trace the
various possible shortest paths from each of the acti-
vated signaling intermediates to the set of seven short-
listed TFs described in Figure 3B. These paths were
then merged to yield the shortest path network from
the signaling intermediates to the TFs.
In the final step we merged the three sub-networks
comprising of the links between the BCR and the signal-
ing intermediates, the signaling intermediates and the
TFs, and the DOR between the TFs and the target
genes described in Figure 3B. This synthesis generated
an information-centric network that captured the path-
ways mediating BCR-dependent cell cycle arrest of CH1
cells. The resulting network was comprised of 163
nodes and 416 edges and is depicted in Figure 3. Here,
44 of the constituent nodes (highlighted in grey) are
transcription factors whereas 103 (highlighted in blue)
are signaling molecules. It is pertinent to note here that
the network shown in Figure 3C is distinct from the
more conventional protein-protein interaction (PPI), or,
gene-regulatory networks in that it represents a hybrid
of both approaches. Thus while the links from the BCR
through the signaling intermediates and to the TFs
essentially constitute a PPI network, the downstream
component incorporating links from TFs to the target
genes - however - describes a set of protein-to-gene
interactions.
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Integration of PPI databases
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confidence interactions
Experimental results
Signaling intermediates 
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TFs affected > 2 fold
Eleven Genes upregulated by anti-IgM
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prediction and literature 
curation of TF binding sites 
Upstream of 11 genes
Trace all possible shortest paths from BCR 
to activated signaling intermediates
Signaling and TF network 
Controlling G1 arrest
A
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C
Trace all possible shortest paths from 
signaling intermediates to shortlisted TFs
Figure 3 Extracting the BCR-dependent network that regulates the cellular response. The Schematic of the analysis performed to identify
the core regulatory network inducing G1 arrest upon anti-IgM stimulation by combining our experimental data and publicly available PPI
databases using network analysis is shown in panel A. Panel B depicts the dense overlapping regulatory module identified for TFs regulating the
early induced genes due to BCR receptor stimulus. This was achieved by applying TFBS prediction algorithm and literature curation. The red
nodes are the early genes induced genes. The yellow nodes represent TFs activated while the blue nodes represent the TFs repressed either at
20 or 40 minutes. Panel C shows the network emanating from BCR that induces changes in the activity of key signaling intermediates analyzed
(green nodes) leading to either activation or repression of the set of transcription factors identified from TF array (The nodes are colour coded as
in panel B). The nodes in light blue and grey represent other signaling and transcriptional intermediates identified from the network analysis.
The set of genes affected due to anti-IgM stimulation are represented as red nodes. All the intermediate nodes are labeled to human orthologs
with their corresponding Entrez Gene ID.
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Extracting the gene expression signature of the cellular
response
Our next goal then was to delineate the core pathways
or modules in the network described in Figure 3C, that
specifically regulated the cellular phenotypic response.
To do this, however, it was first necessary to identify
those BCR-dependent genes described in Figure 3B, that
were responsible for enforcing G1 arrest of cycling CH1
cells. Here, we took advantage of our earlier studies in
which we had determined the early BCR-dependent
gene expression profile in A20 cells. While these latter
cells also represent a murine B-lymphoma line these,
however, are derived from mature B-cells and are char-
acterized by the memory phenotype [1]. Further, BCR-
stimulation of these cells (with anti-IgG) had no effect
either on their survival, or on their ability to complete
the individual stages of the cell cycle [41].
Interestingly, four of the upregulated genes (EGR1,
FOSB, CD69, TNFa) described in Figure 3B were also
found to be induced in A20 cells that had been stimu-
lated through the BCR for 1 h [1] (Accession No.
E-TABM-360). This suggested to us that the products
of these four genes were unlikely to contribute towards
the G1 arrest of CH1 cells. As a result, the list of possi-
ble mediators of the BCR-dependent CH1 cellular
response could be reduced to the seven genes that
remained (i.e. AXUD1, DDIT3, CD274, ATF3, DUSP2,
RGS1, ZFP36). To evaluate the possible relevance of
members of this latter group, we resorted to a func-
tional approach that involved siRNA-mediated silencing.
That is we employed target-specific siRNA to silence
the BCR-dependent expression of each of these seven
genes, and examined for the consequences on the cell
cycle arrest response (Additional File 1: Supplemental
Fig. S2). Figure 4A shows that silencing of each of these
genes resulted in a partial inhibition of the anti-IgM-
induced arrest of cycling CH1 cells. As opposed to this,
silencing expression of either CD69 or TNFa - BCR-
dependent genes that are induced in both A20 and CH1
cells - had no such effect (Figure 4A). These results,
therefore, support that the effects of BCR stimulation on
cycling CH1 cells is, at least in part, mediated through
the collective effects - either additive or cooperative - of
the seven target genes short-listed above (see Figure
4A). Thus, in other words, induced expression of these
target genes likely represents the signature of the anti-
IgM-mediated response of cell cycle arrest in CH1 cells.
It is pertinent to note here that our inferred role for
these seven target genes as contributors towards cell
cycle arrest is also consistent with their known functions
in the literature. Thus, ZFP36 has recently been
described to mediate as an inhibitor of G1 to S progres-
sion in pro-B cells [42], whereas either anti-proliferative
or pro-apoptotic roles have been described for both
DUSP2 and AXUD1 [43,44]. The product of the RGS1
gene has been shown to function as a negative regulator
of G-protein coupled receptor signaling and, therefore,
has been implicated in inducing apoptosis [45]. In a
similar vein, ATF3 is a known repressor of transcription
and is involved in regulation of apoptosis in several cel-
lular systems [46], while DDIT3 causes G1 arrest under
cellular stress conditions through binding with CDK2
[47]. CD274 is also alternatively known as programmed
cell death ligand-1 (PD-L1) and its receptor PD-1 func-
tions as an immunoinhibitory receptor that is primarily
expressed on B-lymphocytes, T-lymphocytes and mye-
loid cells [48]. The effects of PD-1 engagement by
PD-L1 have primarily been studied in T cells where
inhibition of proliferation has been observed [48]. Inter-
estingly, an analysis of the gene expression profile in
unstimulated CH1 cells revealed that PD-1 was also
constitutively expressed in these cells (Accession No.
E-TABM-360). This raises the likelihood that the anti-
IgM-induced expression of PD-L1 may initiate intercel-
lular interactions where PD-L1 engages and, therefore,
activates the constitutively expressed PD-1 on the neigh-
boring cell.
Resolving the response-specific BCR-dependent cell
regulatory network
Having defined the gene expression signature for indu-
cing cell cycle arrest in stimulated CH1 cells, we next
wanted to describe the sub-network of signaling path-
ways that mediated the regulation of these genes. To do
this we adopted an approach in which perturbations
were introduced in the BCR-dependent signaling net-
work through the selective inhibition of several of the
constituent nodes. The consequences of this inhibition
on the anti-IgM induced cellular response were then
monitored. Node-specific inhibition was achieved by the
use of pharmacological inhibitors and these, along with
their kinase-specificity are listed in Figure 4B. Experi-
ments in which CH1 cells were stimulated with anti-
IgM in the presence of each of these inhibitors revealed
that only KN62 and SB203580 - highly specific inhibi-
tors of CAMKII and p38 MAPK respectively [49] - were
able to reverse the block in cell cycle progression to any
significant extent (Figure 4C). In contrast addition either
of wortmannin, rottlerin, or U73 led to an increase in
cell death even in the absence of any stimulation,
whereas none of the remaining inhibitors had any effect
on the anti-IgM-dependent G1 arrest (data not shown).
Since KN62 and SB203580 were both able to inhibit
the effects of anti-IgM, we also examined for their
effects on IgM-dependent gene expression. CH1 cells
were stimulated either in the presence or absence of
these inhibitors and the consequent expression of the
seven cell cycle-regulatory genes short-listed from
Jamal et al. BMC Systems Biology 2010, 4:169
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Figure 3B was determined by quantitative RT-PCR
(Additional File 3). The results obtained are summarized
in Figure 4D. As shown, both pharmacological agents
inhibited BCR-dependent induction of all seven genes
although the effects of SB203580 were significantly
more potent than that of KN62 (Figure 4D). The inhibi-
tory effect of KN62 ranged from modest (ATF3) to sig-
nificant, whereas that of SB203580 ranged from one that
was near quantitative (DUSP2, RGS1, ZFP36) to a
marked repression to below basal levels (ATF3, AXUD1,
CD274, DDIT3) (Figure 4D). Thus the ability of the
CaMKII inhibitor KN62, and that of the p38 inhibitor
SB203580 to prevent BCR-dependent cell cycle arrest
correlates with their ability to also block expression of
the genes that presumably drive this response. Interest-
ingly, although SB203580 was more potent than KN62
at inhibiting anti-IgM-specific gene expression (Figure
4D), both compounds were - nonetheless - similarly
effective at inhibiting the cell cycle arrest response (Fig-
ure 4D). This may suggest a relatively high threshold of
vulnerability for the products of these genes, with the
magnitude of the reduction in their levels achieved by
KN62 being sufficient to neutralize their effects on the
cell cycle. Consequently then, the greater potency of
SB203850 - at the level of gene expression - would not
necessarily translate into a greater inhibition of the
effects of anti-IgM on the cell cycle.
Dissection of the perturbations induced by KN62 and
SB203580 on the BCR-signaling network
Since we had two separate inhibitors that similarly sup-
pressed the effects of anti-IgM stimulation, it became
possible to use these to dissect the core pathways
involved. CH1 cells were stimulated with anti-IgM either
in the presence or absence of either SB203580 or KN62,
and the effects on time-dependent phosphorylation of
the fourteen BCR-sensitive signaling intermediates (see
Figure 1B) was monitored (Additional File 1: Supple-
mental Fig. S1). The resulting normalized and quantified
profiles obtained are shown in Figure 5A.
Interestingly, although highly specific for p38 [50], the
addition of SB203580 led to a significant inhibition in
BCR-dependent phosphorylation of all the signaling
intermediates examined (Figure 5A). The only exception
here was CaMKII where the inhibitory effect was mar-
ginal (Figure 5A). A similar effect of a near global inhi-
bition of BCR-dependent signaling was also observed in
response KN62 addition (Figure 5A). In this case, how-
ever, phosphorylation of p38 was also inhibited (Figure
5A). That is, while inhibition of CaMKII also led to
attenuation of p38 phosphorylation the reverse was,
however, not the case (Figure 5A).
While a mechanistic explanation for these differential
effects was not immediately obvious these latter results,
nonetheless, suggested that the effects of CaMKII inhibi-
tion may also be mediated through the consequent inhi-
bition of p38 activation. Here it must be emphasized that
both KN62 and SB203580 are reported as highly specific
inhibitors of CaMKII and p38 activity thus excluding the
possibility of off-target effects that might arise [49].
The perturbations in the BCR-signaling network
induced by these two pharmacological inhibitors also
resulted in profound effects at the level of the BCR-
sensitive TFs. This is apparent from the heat map
shown in Figure 5B, which compares the fold change in
activity of individual TFs at 20 and 40 minutes of stimu-
lation with anti-IgM either in the absence or presence of
these inhibitors. The green and red maps represent a
>2-fold repression and activation respectively, while the
grey map is indicative of no change in activity. Broadly
speaking, it is evident that both the inhibitors employed
significantly attenuate the effects of anti-IgM, during
either the enhancement or suppression of TF activities
(Additional File 1: Supplemental Fig. S3).
For our further analysis, we concentrated on examin-
ing the activation profiles of only those seven TFs that
were short-listed in Figure 3B. This was because our pri-
mary aim was to extract the pathways through which
signal perturbation by KN62 and SB203580 influenced
the gene expression pattern observed in Figure 4D. As
shown in Figure 5C, stimulation of cells with anti-IgM
led to repression in the activity of MZF1. This inactiva-
tion, however, was inhibited in the presence of both
KN62 and SB203580 (Figure 5C). Similarly, the anti-IgM
induced inactivation of Sp1 was also partly inhibited by
SB203580, whereas this inactivation was delayed in the
presence of KN62 (Figure 5C). Somewhat surprisingly,
stimulation also resulted in a rapid reduction of the
basal activity of NFATc2. Further, while inhibition of
p38 had no significant effect on this process, the inclu-
sion of KN62 lead to at least a delay in the kinetics of
this inactivation (Figure 5C). In contrast to these repres-
sive effects, BCR-crosslinking also induced a delayed
enhancement in the activities of FOSL1, TBP, NFKB1
and - to lesser extent - TRP53 (Figure 5C). However,
inhibition of either CaMKII or p38 led to a near com-
plete suppression of this activation in the case of
FOSL1, TBP, NFKB1, but not of that of TRP53 (Figure
5C). Thus, in at least four of the seven cases, both inhi-
bitors exerted comparable effects on their anti-IgM-
induced activation profiles. The reasons for the differ-
ences observed in the remaining three TFs are unclear
at the present time. Notwithstanding this however, the
results in Figure 5C permitted us to infer that the four
similarly affected TFs - MZF1, FOSL1, TBP, and NFKB1
- could at least partly rationalize the overlapping effects
of these two inhibitors on anti-IgM-stimulated cells,
both at the level of gene expression and cell cycle arrest.
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Figure 4 Identifying the key molecular intermediates involved in mediating BCR-dependent cell cycle arrest. Panel A shows the
population of G1 arrested cells under RNAi mediated knockdown of early induced genes identified as immature B cell specific. The plot
represents mean of three individual replicates with ± S.D. Panel B lists chemical inhibitors screened for protection of CH1 cells from anti-IgM
mediated G1 arrest to identify potential regulatory signaling intermediates. Panel C shows the histograms of live population of cells in each of
the cell cycle phases under normal anti-IgM stimulation, in presence of p38 inhibitor SB203580 and CaMKII inhibitor KN62. The decrease in the
population of G1 arrested cells in both the cases of SB203580 and KN62 could be clearly observed in the histograms. Effect of SB203580 and
KN62 on early induced genes one hour after anti-IgM stimulation is shown in panel D. The plot indicates mean value of the fold change in the
mRNA levels of the respective genes in log scale obtained from three replicates with ± S.D.
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Figure 5 Delineating the core molecular constituents of the BCR-dependent pathways mediating cell cycle arrest. Panel A depicts the
time dependent phosphorylation status of signaling intermediates upon anti-IgM stimulation in presence of p38 inhibitor SB203580 and CaMKII
inhibitor KN62. Values are mean of three individual experiments with ± S.D. Modulation of Transcription factor activities upon BCR stimulation in
the presence of SB203580 and KN62 is shown in panel B. The TF array blots after quantification and normalization are represented as heat map
to represents the fold changes in TF activity expressed on a log10 scale. Panel C shows the activity profiles of seven TFs short listed based on
their effect of early-induced genes in presence of the p38 and CaMKII inhibitors (see text for details). Shown here are the actual quantitative
numbers obtained after image quantification.
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The p38 MAP kinase influences BCR signaling through a
constitutively active feedback regulation of Lyn
The results in Figure 5A that inhibition of p38 led to a
concomitant inhibition of nearly all the BCR-dependent
signaling intermediates was particularly intriguing.
Importantly, this also included the protein tyrosine
kinase Lyn. The src kinase family member Lyn repre-
sents one of the earliest kinases recruited by the BCR,
the activation of which then ensures activation of the
downstream signaling pathways [51-54]. Consequently,
suppression of Lyn activation by p38 inhibition offered a
simple explanation for the near global effect of
SB203580 on BCR-signaling. In other words, these
results suggested the likely existence of a positive feed-
back regulatory loop where p38 also influences Lyn acti-
vation. Relevant to this was the finding in Figure 5A
that addition of SB203580 induced a reduction in phos-
pho-Lyn levels even in the absence of any stimulation of
cells with anti-IgM. That is, p38 may constitutively
interact with Lyn even in the absence of BCR
engagement.
To verify this we first tested the effects of a panel of
pharmacological inhibitors, including SB203850 and
KN62, on the basal phosphorylation of Lyn in CH1
cells. As shown in Figure 6A, none of these inhibitors
had any significant effect on intracellular concentrations
of the Lyn protein. Levels of its phosphorylated form
were, however, markedly reduced in cells treated with
SB203580. Importantly, this effect on Lyn phosphoryla-
tion was specific for SB203580 with none of the other
inhibitors tested, including KN62, showing such an
activity (Figure 6A). Thus, at least in CH1 cells, the Ser/
Thr kinase p38 appears to regulate the basal activation
status of the protein tyrosine kinase Lyn.
We have previously shown that the phosphorylation
state of Lyn in B cells is governed by the activity of the
BCR-associated protein tyrosine phosphatase (PTP)
SHP-1 [51]. Interestingly, studies from other groups
have demonstrated that the activity of SHP-1 can, in
turn, be regulated through phosphorylation at specific
Ser/Thr residues [55]. It, therefore, seemed plausible to
us that p38-dependent modulation of basal phospho-
Lyn levels may represent an indirect effect that is
mediated through SHP-1. That is, the enhanced basal
levels of activated Lyn could represent a consequence of
attenuated SHP-1 activity, which is enforced through its
phosphorylation by p38. The possibility of a direct inter-
action between p38 and SHP-1 was supported by our
initial results involving confocal microscopy, which
revealed that at least a fraction of the molecules repre-
senting these two proteins were indeed co-localized in
the proximity of the cell membrane (Figure 6B, C). Sub-
sequent immunoprecipitation experiments established
that this co-localized pool also included that subset of
SHP-1 that was constitutively associated with the BCR.
Thus, a Western blot analysis of BCR immunoprecipi-
tated from either unstimulated or anti-IgM-stimulated
CH1 cells also revealed the co-precipitation of both
SHP-1 and p38 (Figure 6D). Finally, we could further
demonstrate that treatment of the BCR immunoprecipi-
tate with the p38 inhibitor SB203580 resulted in a sig-
nificant increase in the associated phosphatase activity
(Figure 6E). These collective results, therefore, confirm
that activity of the BCR-associated SHP-1 was indeed
under negative control of the co-associated p38. This, in
turn, provides a likely explanation for the increased
levels of activated Lyn detected in un-stimulated CH1
cells.
Extracting the core cellular network that mediates BCR-
dependent cell cycle arrest CH1 cells
Our results so far had helped to characterize at least
some of the intermediates that were involved during
anti-IgM induced signal transduction. In subsequent
experiments, we were also able to define the key set of
TFs that were responsible for translating the pattern of
signaling events generated into the expression of those
target genes that were, at least primarily, involved in
driving the G1 phase arrest. Having thus generated the
molecular map of the network emanating from the BCR
and extending up to the enforcement of the specific cel-
lular response, we then also identified a feedback inter-
action between p38 and SHP-1 that functioned, through
the regulation of Lyn activity, as a key regulatory motif
of this network.
These cumulative results, therefore, allowed us to
further refine the rather generic network map derived in
Figure 3C, and obtain a more precise description of the
BCR-dependent regulatory network for G1 arrest in
CH1 cells. By combining known experimental pathway
information on B cell signaling, and the network derived
through a shortest path analysis, we could generate the
CH1 cell-specific signaling axis responsible for driving
G1 arrest (Figure 7A). Further, we could also distinguish
the individual stages based on the sequential steps of
initiation, propagation, and integration of intracellular
signal transduction cascades (see Figure 7A). The step
of signal initiation is considered to represent the early
events that occur upon receptor engagement, and this
early upstream process regulates the downstream targets
both qualitatively and quantitatively.
A mathematical model helps to define key regulators of
system homeostasis and Lyn activation
Although we could successfully prove the role of p38 in
regulation of Lyn by acting on SHP-1, it did not address
the issue of cell type specificity in determining cell
fate decisions. It has been reported that levels of
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Figure 6 The MAP kinase p38 indirectly regulates the activation status of Lyn. Shown in panel A are phosphorylation levels of Lyn in
presence of a panel of inhibitors with Lyn molecule as loading control. The images in panel B confirm the existence of a co-localized pool of
p38 and SHP-1 in unstimulated CH1 cells. Further, increase in the extent of co-localization was also observed after anti-IgM stimulation for 5 min.
Panel C shows the Pearson’s co-localization coefficient for p38 and SHP1 obtained from the images in panel B. Values obtained in both
unstimulated and anti-IgM-stimulated (5 min) are plotted. Experiments were performed in triplicates and mean value ±S.D. is plotted (* indicates
p-value < 0.05). Panel D shows the results of an experiment where the BCR was immunoprecipitated from either unstimulated, or anti-IgM-
stimulated (5 min) cells. Immunoprecipitates were then resolved by gel electrophoresis and then probed for the presence of either p38, SHP-1 or
Lyn by Western blot analysis. Results shown confirm that all of these three molecules were associated with the BCR in both unstimulated and
stimulated cells. In addition, these results further confirmed the findings of p38-SHP-1 co-localization in panel B and C. The negative control
shown represents a Western blot for Lyn in samples where mouse IgM conjugated to agarose was used for the immunoprecipitation. A similar
negative result was also obtained when these samples were probed for presence of either p38, or SHP-1 (not shown). Panel E shows
phosphatase activity present in immunoprecipitates of the BCR that were obtained from unstimulated cells either in presence or absence
(Normal) of the p38 inhibitor SB203580 (Materials and Methods). The assay was performed in triplicates and the mean value (± S.D.) is given, *
indicate statistically significant (p-value < 0.05) increase in phosphatase activity in presence of SB203580.
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Figure 7 Defining the core regulatory axis and modeling the role of system homeostasis. The molecular interaction map that we derived
by combining our experimental data with known literature on BCR signaling is shown in panel A (see text for details). The novel feedback
regulation of SHP-1 mediated by p38 that we identified is depicted by red edges. The turquoise nodes represent the seven TFs identified by TF
array, and the red nodes are the early induced genes specific to CH1 cells. The signaling intermediates are denoted in green nodes and edge
label denote either phosphorylation (pp) or dephosphorylation (dp) regulation. The cascade is classified into signal initiation and propagation
sub groups for better understanding. Panel B shows different concentrations of the phopho-Lyn and Syk for different basal values of Lp i., e., Lp*.
For the straight line d1 = 0.25 and for the dotted line d1 = 1.1, with other parameter values given in the Table 1. Panel C shows the relation
between Lp* and the peak value of the concentration of Lp after stimulation is shown in panel C. Here we vary d1 from 0.23 to 1.2 in the reverse
order, with other parameter values as in the Table 1. Panel D shows relation between Lp* and the peak value of the concentration of Sp (after
stimulation) by varying d1 for different values of k3 (from 0.001 to 0.01), with other parameter values as in the Table 1. Panel E shows relation
between Lp* and the peak value of the concentration of Sp (after stimulation) by varying d1 for different values of d2 (from 0.1 to 0.8), with other
parameter values as in the Table 1.
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phospho-Lyn and other intermediates are significantly
higher in immature B cell compared to the mature coun-
terpart cells [52]. We also observed this feature in our
present study, when compared with our earlier studies
involving mature B cells [1,51]. Since we had sufficient
information on both mature and immature counterparts
regarding their basal status and the way they respond to
the antigen we sought to build a mathematical model
representing the fundamental differences in both of these
cell types, in terms of the initiation of BCR signaling.
For this we built a model based on a system of ordin-
ary differential equations to analyze Lyn activation and
it’s down stream effect on Syk activation. Here, while
the extent of BCR-dependent Lyn activation by phos-
phorylation was treated as a measure of the strength of
initial signal generated, the magnitude of Syk activation
would then define the efficiency of its transduction to
the downstream intermediates [51]. The aim here was
to identify the key parameter(s) that might lead to weak
activation of BCR-dependent signals in immature B
cells, as opposed to that in mature B cells. More specifi-
cally, we wanted to determine whether the higher levels
of basally active Lyn in immature B cells could account
for this difference. In our model, we also incorporated
the role of SHP-1 as a negative regulator of BCR signal-
ing. It is now widely accepted that receptor-associated
phosphatases function as key negative regulators that
keep the system in steady state in the absence of an
activating ligand. Following engagement of the receptor,
however, there is a transient decrease in the negative
regulatory activity of this phosphatase, after which it
again returns to its initial value [51]. Thus, if Lp denotes
the concentration of activated Lyn molecule; Sm that of
the Syk molecule susceptible to activation by phosphor-
ylation; and Sp denotes the concentration of activated
Syk, the model - with the meaning of each parameter -
can be written as follows:
dL
dt
k k L d g t L
dS
dt
A k S L
dS
dt
k S L d S
p
p p
m
m p
p
m p p
= + −
= −
= −
1 2 1
3
3 2
( ) ,
, (1)
With initial conditions Lp (0) ≥ 0, Sm(0) ≥ 0, Sp(0) ≥ 0.
A is the total amount of Syk molecule present in the
cell susceptible to activation; k1 is the membrane asso-
ciated Lyn at basal level; k2 represents the rate at which
activation of Lyn take place after the binding of agonist
to the membrane receptor; k3 is the rate at which Syk is
activated by the Lyn; d1 and d2 represents the amount
of negative regulator on the active forms of Lyn and Syk
respectively at their ground state.
To take into account the particular nature of the
negative regulator as discussed above we assumed,
g t
t
( ) sin= −1
2 
Here a is the forcing term representing the strength
of the stimulation. At ground state a = 0.
In unstimulated cells, there is an equilibrium main-
tained between the active and inactive state of the sig-
naling molecules such as Lyn and Syk. However, it must
be emphasized here that there are indeed multiple states
of signaling intermediates (like Lyn, Syk) present in the
real system due to multiple phosphorylation sites. But
our focus here was to analyze the balance between the
active and inactive forms of the species and their differ-
ential response to varying basal activity. Therefore in
the considered scenario, mathematically, at ground state
i.e., a = 0, we define the basal value of active-Lyn (Lp)
denoted by Lp* as the value where,
dL
dt
p
= 0
Using the definition of Lp* if we solve the equation (1)
we get the value of Lp* as given below (detailed calcula-
tions provided in (Additional file 1),
L
k
d k
p* =
−
1
1 2
Thus our mathematical result suggests that, at ground
state, the basal value is inversely related to the magni-
tude of the negative regulator acting on the activated
Lyn molecule.
We next simulated our model system (1) (the para-
meter values and the method of simulation are
described in Additional file 1) and the results for Lyn
and Syk activation are shown in Figure 7A and 7B.
Here, we calculated the value of Lp* from the derived
relation. We found that the influence of the negative
regulator on Lyn and Syk activity produced two different
basal states for them before the trigger point, which
denotes BCR-dependent stimulation. But the interesting
prediction from the model was that the sensitivity of
either Lyn or Syk response to BCR-engagement was sig-
nificantly higher when the basal activity of Lyn was
lower. This finding would be consistent with the experi-
mental results obtained in the present study. To further
delineate the effect of basal activity on receptor-induced
signaling, we plotted different peak values with respect
to different basal values for Lyn and Syk by varying the
parameter for negative regulator. Figure 7C shows the
result of the simulation where an inverse relation
between basal level of Lyn activity, and the extent of its
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activation after BCR stimulation is clearly evident. To
observe the effect of other parameters especially those
acting on the active Syk species we performed a similar
analysis on Syk. A similar qualitative behaviour with dif-
ferent slope values was again obtained (Figure 7C, D).
The results of our modeling analysis thus further sub-
stantiated our experimental results by highlighting the
role played by the negative regulators of signal initiation,
such as SHP-1, in determining the cell fate decision.
Discussion
B-lymphocytes represent a good model system to study
plasticity in receptor-activated signaling processes, and
the consequent influence on the cellular phenotypic
response. Depending on their state of maturation, anti-
gen encounter by the B-lymphocytes can lead to varied
outcomes that range from activation and/or proliferation
to anergy, or also to activation induced cell death
(AICD) through apoptotic mechanisms [56]. In general,
mature B-lymphocytes undergo activation followed by
proliferation upon induction of BCR-dependent signal-
ing by an antigen [57,58]. In contrast, engagement of
the BCR induces AICD - preceded by an arrest of the
cell cycle - in immature and transitional stage immature
B cells [41,56]. This latter process serves to eliminate
self-reactive B cells during its different stages of devel-
opment [41,56]. Various cell lines such as WEHI-231,
CH31, and B104 among others have been employed as
models systems for the study of BCR signaling in imma-
ture B cells. In all of these cases, cell stimulation with a
suitable surrogate antigen leads first to G1 cell cycle
arrest, which is then followed by apoptosis [56,59].
Both the results presented here as well as those
described in earlier studies confirm that CH1 cells
represent yet another good model system for recapitu-
lating BCR-driven responses in immature B cells. First,
similar to immature and transition stage immature B
cells, CH1 cells also express high levels of the IgM class
of the BCR, with little or no expression of those belong-
ing to the IgD class [11,12]. In immature B cells, BCR-
activated cells fail to enter into the S phase and this
effect can be reversed by treatment with IL4 [60]. As we
have previously shown, CH1 cells also exhibit similar
properties [20]. BCR activation shows contrasting effects
on p27 expression in mature versus immature B cells.
Mature B cells express high levels of p27, which is then
downregulated by antigenic stimulation [56]. The situa-
tion is reversed in the case of immature B cells where,
while the basal levels of this protein are low, BCR
engagement leads to rapid upregulation [56]. As shown
in this study, CH1 cells also accurately recapitulate this
latter situation. In transitional immature B cells, anti-
genic stimulation leads to a transient activation of the
downstream signaling components including that of
Akt/PKB and those belonging to the MAP kinase path-
way [53]. This feature was also evident in our present
examination of BCR signaling in CH1 cells. Finally, the
greater extent of ERK phosphorylation relative to that of
JNK and p38 observed here was yet another property
that is characteristic of antigen-stimulated immature B
cells [61]. Thus these comparisons collectively confirm
the suitability of CH1 cells as a model for studying
mechanisms regulating BCR-induced cell cycle arrest
and subsequent apoptosis in immature, transitional
stage, B-lymphocytes.
An important aspect of our present study was the sys-
tems approach that we adopted, which integrated exten-
sive experimentation with graph theoretical analysis and
mathematical modeling. It was the synthesis of these
diverse methodologies that enabled us to eventually
obtain a comprehensive view on both the quantitative
and qualitative features of the BCR-dependent signaling
network. In addition it also facilitated a description of the
consequent changes in the transcription regulatory
machinery, and the downstream effects on changes in
expression levels of those genes that eventually contribu-
ted towards enforcing a G1 phase-specific arrest of the
cell cycle. Of particular note here was our finding that
the cellular response was, in all likelihood, a direct conse-
quence of the selective and transient activation of the
BCR signaling network. Thus, of the twenty molecules
examined, we were only able to observe BCR-dependent
phosphorylation for fourteen, with no significant effects
being evident for the remaining six molecules. This latter
group included the adaptor molecules SHC and BLNK,
the anti-apoptotic protein Bcl2, the NF-kB activating
kinase IKKa, and the cellular kinases Pyk2 and PDPK1.
While the absence of phosphorylation of Bcl2 and IKKa
may not be surprising in view of the pro-apoptotic
response induced by anti-IgM, that the adaptor mole-
cules SHC and BLNK were also not phosphorylated was
- however - particularly intriguing. At least in mature B
cells, both of these scaffolding proteins play a key role in
the assembly of BCR-dependent signaling complexes on
the cytoplasmic side of the cell membrane, and are
important for fine-tuning BCR signaling to direct appro-
priate cell fates [62,63]. Even in instances where the
extent of anti-IgM-induced phosphorylation was more
significant, this was only transient in most cases with
levels of the respective phospho-protein progressively
declining after reaching their peak value. The weak per-
turbation of the transcription regulatory network, leading
to a biased expression of those early response genes that
were involved in the cell death pathways, was presumably
a direct outcome of the sparse nature of the BCR signal-
ing network in these cells.
We believe that successful extraction of the core BCR-
dependent regulatory network that enforced cell cycle
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arrest in CH1 cells represents a key highlight of our
study. Its significance lies in the fact that this network
encompasses pathways emanating from the BCR to the
key signaling intermediates, and then also those extend-
ing from these intermediates to the TFs that were criti-
cal for inducing expression of the pro-apoptotic genes.
This could be achieved by employing an in silico based
network approach that combined the data on BCR-acti-
vated signaling events, with that on modulation of TF
activities. Further, this approach also enabled us to inte-
grate the DOR motif that linked these TFs to the effec-
tor genes. Importantly here, the effector genes
responsible for causing G1 arrest could first be identi-
fied through a comparison of the early gene expression
profile between CH1 and mature B cells, and then func-
tionally verified in experiments involving their selective
depletion by siRNA.
Having delineated the core BCR-dependent molecu-
lar network that specified the G1 arrest, we could then
test the effects of specific perturbations so as to iden-
tify the key signaling intermediates involved in driving
this response. By using a panel of pharmacological
inhibitors against different kinases, we localized p38
and CAMKII as the likely targets. Such an inference
could be derived from our observations that, of the
inhibitors tested, only those specific for either of these
kinases were capable of at least partially reversing anti-
IgM-induced G1 arrest of the cells. A subsequent
examination of the expression profile of the effector
gene subset revealed that p38 inhibition was more
effective at inhibiting induction of these genes, thus
identifying p38 as the central regulator of the anti-IgM
induced cell cycle arrest response.
Conclusions
Interestingly, the mechanism by which p38 exerted such
a prominent effect involved a novel feedback loop that
controlled signal amplification at a level that was imme-
diately proximal to the BCR. As we showed, p38 directly
regulated activity of the BCR-associated phosphatase
SHP-1, which in turn influenced the activity of Lyn, the
earliest intermediate involved in BCR signaling. Thus,
p38 mediated attenuation of SHP-1 activity led to
increased basal levels of Lyn phosphorylation, thereby
rendering it less sensitive to BCR activation. The selec-
tive and transient activation of the signaling network
then was direct consequence of the dampening of the
initiating signal from the BCR. This aspect could be
further elaborated by the simple mathematical model
that we developed to analyze the parameters involved in
defining the strength of the initial signal generated. Our
model revealed a strong influence of the receptor proxi-
mal negative regulator (SHP-1 in this case), which gen-
erally balances against positive signals to ensure system
homeostasis [51]. By using this model we could confirm
that as the basal activation of Lyn increased, due to
reduced activity of SHP-1, the sensitivity of this kinase
to the BCR also diminished. As a result, transmission of
signal to the downstream intermediates was also nega-
tively affected at least when measured at the level of Syk
activation.
At one level these latter findings served to rationalize
the sparse character of the BCR signaling network in
CH1 cells and, by extension, immature B-lymphocytes.
In addition to this however, we believe that our revela-
tion of the importance of the basal state of the signaling
machinery in defining sensitivity, and thereby the cellu-
lar response, to the activation of cell surface also has
important bearings from a broader point of view. Thus,
differences in the basal phosphorylation state of at least
the early signaling intermediates could well explain how
variations in the response to the same external stimulus
are generated from cells that differ either at the level of
tissue type, or activation state [64].
Additional material
Additional file 1: This contains the complete List of Additional Files
including tables, figures and additional methods.
Additional file 2: This contains the list of TFs probed by the combo
array and their corresponding activation pattern. This file also
contains the information regarding the Entrez Gene IDs of the TFs
shown in Figure 2.
Additional file 3: This file contains the complete information of the
RT-PCR data and analysis.
Acknowledgements
This study was funded by a grant (KVSR) from the Department of
Biotechnology, Govt. of India. We thank Dr. Virendra K. Chaudhri for critical
reading of the manuscript. MSJ, SR and NJ are recipients of the Senior
Research Fellowship from the Council of Scientific and Industrial Research,
Govt. of India.
Author details
1Immunology Group, International Centre for Genetic Engineering and
Biotechnology, Aruna Asaf Ali Marg, New Delhi - 110067, India. 2Department
of Physics and Astrophysics, University of Delhi, New Delhi - 110007, India.
Authors’ contributions
MSJ performed the western blots, TF array profiling, cell cycle analysis and
validation experiments, SR conceived the project, analyzed and interpreted
the results, NJ performed the cell cycle analysis and western blots. SC built
the mathematical model, RD performed the confocal studies. MSJ, SR and NJ
prepared the manuscript. KVSR conceived and managed the overall project
and contributed to manuscript preparation. All the authors read and
approved the final manuscript.
Received: 16 June 2010 Accepted: 9 December 2010
Published: 9 December 2010
References
1. Kumar D, Srikanth R, Ahlfors H, Lahesmaa R, Rao KV: Capturing cell-fate
decisions from the molecular signatures of a receptor-dependent
signaling response. Mol Syst Biol 2007, 3:150.
Jamal et al. BMC Systems Biology 2010, 4:169
http://www.biomedcentral.com/1752-0509/4/169
Page 19 of 21
2. Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA: Common effector
processing mediates cell-specific responses to stimuli. Nature 2007,
448(7153):604-608.
3. McKenna NJ, O’Malley BW: Combinatorial control of gene expression by
nuclear receptors and coregulators. Cell 2002, 108(4):465-474.
4. Ma’ayan A: Insights into the organization of biochemical regulatory
networks using graph theory analyses. J Biol Chem 2009,
284(9):5451-5455.
5. Barabasi AL, Oltvai ZN: Network biology: understanding the cell’s
functional organization. Nat Rev Genet 2004, 5(2):101-113.
6. Bromberg KD, Ma’ayan A, Neves SR, Iyengar R: Design logic of a
cannabinoid receptor signaling network that triggers neurite outgrowth.
Science 2008, 320(5878):903-909.
7. Natarajan M, Lin KM, Hsueh RC, Sternweis PC, Ranganathan R: A global
analysis of cross-talk in a mammalian cellular signalling network. Nat Cell
Biol 2006, 8(6):571-580.
8. Kawauchi J, Zhang C, Nobori K, Hashimoto Y, Adachi MT, Noda A,
Sunamori M, Kitajima S: Transcriptional repressor activating transcription
factor 3 protects human umbilical vein endothelial cells from tumor
necrosis factor-alpha-induced apoptosis through down-regulation of p53
transcription. J Biol Chem 2002, 277(41):39025-39034.
9. Madan Babu M, Teichmann SA: Evolution of transcription factors and the
gene regulatory network in Escherichia coli. Nucleic Acids Res 2003,
31(4):1234-1244.
10. Basso K: Toward a systems biology approach to investigate cellular
networks in normal and malignant B cells. Leukemia 2009,
23(7):1219-1225.
11. Lanier LL, Arnold LW, Raybourne RB, Russell S, Lynes MA, Warner NL,
Haughton G: Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts
mice. Immunogenetics 1982, 16(4):367-371.
12. Lanier LL, Lynes M, Haughton G, Wettstein PJ: Novel type of murine B-cell
lymphoma. Nature 1978, 271(5645):554-555.
13. Niiro H, Clark EA: Regulation of B-cell fate by antigen-receptor signals.
Nat Rev Immunol 2002, 2(12):945-956.
14. Yoshida K, Kufe D: Negative regulation of the SHPTP1 protein tyrosine
phosphatase by protein kinase C delta in response to DNA damage. Mol
Pharmacol 2001, 60(6):1431-1438.
15. Bookout AL, Mangelsdorf DJ: Quantitative real-time PCR protocol for
analysis of nuclear receptor signaling pathways. Nucl Recept Signal 2003,
1:e012.
16. Dimitrova DS, Gilbert DM: DNA replication and nuclear organization:
prospects for a soluble in vitro system. Crit Rev Eukaryot Gene Expr 1999,
9(3-4):353-361.
17. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA: Dynamics of
three-dimensional replication patterns during the S-phase, analysed by
double labelling of DNA and confocal microscopy. J Cell Sci 1992, 103(Pt
3):857-862.
18. Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW: BCR signals
target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to
mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene
2001, 20(50):7352-7367.
19. Nemazee D, Buerki K: Clonal deletion of autoreactive B lymphocytes
in bone marrow chimeras. Proc Natl Acad Sci USA 1989,
86(20):8039-8043.
20. Aflakian N, Ravichandran S, Jamal MS, Jarvenpaa H, Lahesmaa R, Rao KV:
Integration of signals from the B-cell antigen receptor and the IL-4
receptor leads to a cooperative shift in the cellular response axis. Mol
Biosyst 2009, 5:1661-1671.
21. Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA: Structure
and evolution of transcriptional regulatory networks. Curr Opin Struct Biol
2004, 14(3):283-291.
22. Alon U: Network motifs: theory and experimental approaches. Nat Rev
Genet 2007, 8(6):450-461.
23. Green MR: TBP-associated factors (TAFIIs): multiple, selective
transcriptional mediators in common complexes. Trends Biochem Sci
2000, 25(2):59-63.
24. Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV:
Transcription of the RelB gene is regulated by NF-kappaB. Oncogene
2001, 20(53):7722-7733.
25. Basile JR, Eichten A, Zacny V, Munger K: NF-kappaB-mediated induction of
p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest
and cytoprotection in normal human keratinocytes. Mol Cancer Res 2003,
1(4):262-270.
26. Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-
alpha-induced cell death. Science 1996, 274(5288):782-784.
27. Gwack Y, Feske S, Srikanth S, Hogan PG, Rao A: Signalling to transcription:
store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell
Calcium 2007, 42(2):145-156.
28. Rahman-Roblick R, Roblick UJ, Hellman U, Conrotto P, Liu T, Becker S,
Hirschberg D, Jornvall H, Auer G, Wiman KG: p53 targets identified by
protein expression profiling. Proc Natl Acad Sci USA 2007,
104(13):5401-5406.
29. Sahin F, Qiu W, Wilentz RE, Iacobuzio-Donahue CA, Grosmark A, Su GH:
RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic
ductal epithelium. Pancreas 2005, 30(2):158-167.
30. Inoue M, Takahashi K, Niide O, Shibata M, Fukuzawa M, Ra C: LDOC1, a
novel MZF-1-interacting protein, induces apoptosis. FEBS Lett 2005,
579(3):604-608.
31. Huang W, Tan D, Wang X, Han S, Tan J, Zhao Y, Lu J, Huang B: Histone
deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by
interacting with Sp1. Biochem Biophys Res Commun 2006, 339(1):165-171.
32. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MB, Barcinski MA,
Viola JP: NFATC2 transcription factor regulates cell cycle progression
during lymphocyte activation: evidence of its involvement in the control
of cyclin gene expression. Faseb J 2002, 16(14):1940-1942.
33. Bader GD, Betel D, Hogue CW: BIND: the Biomolecular Interaction
Network Database. Nucleic Acids Res 2003, 31(1):248-250.
34. Xenarios I, Fernandez E, Salwinski L, Duan XJ, Thompson MJ, Marcotte EM,
Eisenberg D: DIP: The Database of Interacting Proteins: 2001 update.
Nucleic Acids Res 2001, 29(1):239-241.
35. Kerrien S, Alam-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C,
Dimmer E, Feuermann M, Friedrichsen A, Huntley R, et al: IntAct-open
source resource for molecular interaction data. Nucleic Acids Res 2007, ,
35 Database: D561-565.
36. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV,
Castagnoli L, Cesareni G: MINT: the Molecular INTeraction database.
Nucleic Acids Res 2007, , 35 Database: D572-574.
37. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, Bala P,
Shivakumar K, Anuradha N, Reddy R, Raghavan TM, et al: Human protein
reference database–2006 update. Nucleic Acids Res 2006, , 34 Database:
D411-414.
38. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG: Proteomic
analysis of NMDA receptor-adhesion protein signaling complexes. Nat
Neurosci 2000, 3(7):661-669.
39. Li C, Siemasko K, Clark MR, Song W: Cooperative interaction of Ig(alpha)
and Ig(beta) of the BCR regulates the kinetics and specificity of antigen
targeting. Int Immunol 2002, 14(10):1179-1191.
40. Pereira JP, An J, Xu Y, Huang Y, Cyster JG: Cannabinoid receptor 2
mediates the retention of immature B cells in bone marrow sinusoids.
Nat Immunol 2009, 10(4):403-411.
41. King LB, Monroe JG: Immunobiology of the immature B cell: plasticity in
the B-cell antigen receptor-induced response fine tunes negative
selection. Immunol Rev 2000, 176:86-104.
42. Minagawa K, Katayama Y, Nishikawa S, Yamamoto K, Sada A, Okamura A,
Shimoyama M, Matsui T: Inhibition of G(1) to S phase progression by a
novel zinc finger protein P58(TFL) at P-bodies. Mol Cancer Res 2009,
7(6):880-889.
43. Almeida OF, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH,
Meyer M, Holsboer F, Michaelidis TM: Subtle shifts in the ratio between
pro- and antiapoptotic molecules after activation of corticosteroid
receptors decide neuronal fate. Faseb J 2000, 14(5):779-790.
44. Ishiguro H, Tsunoda T, Tanaka T, Fujii Y, Nakamura Y, Furukawa Y:
Identification of AXUD1, a novel human gene induced by AXIN1 and its
reduced expression in human carcinomas of the lung, liver, colon and
kidney. Oncogene 2001, 20(36):5062-5066.
45. Han JI, Huang NN, Kim DU, Kehrl JH: RGS1 and RGS13 mRNA silencing in
a human B lymphoma line enhances responsiveness to
chemoattractants and impairs desensitization. J Leukoc Biol 2006,
79(6):1357-1368.
46. Demidova AR, Aau MY, Zhuang L, Yu Q: Dual regulation of Cdc25A by
Chk1 and p53-ATF3 in DNA replication checkpoint control. J Biol Chem
2009, 284(7):4132-4139.
Jamal et al. BMC Systems Biology 2010, 4:169
http://www.biomedcentral.com/1752-0509/4/169
Page 20 of 21
47. Bento C, Andersson MK, Aman P: DDIT3/CHOP and the sarcoma fusion
oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2. BMC
Cell Biol 2009, 10:89.
48. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J,
Tanaka T, Yoshida N, Nagata S: Enhanced and accelerated
lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 1996,
93(5):2131-2136.
49. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of
action of some commonly used protein kinase inhibitors. Biochem J
2000, 351(Pt 1):95-105.
50. Swart JM, Bergeron DM, Chiles TC: Identification of a membrane Ig-
induced p38 mitogen-activated protein kinase module that regulates
cAMP response element binding protein phosphorylation and
transcriptional activation in CH31 B cell lymphomas. J Immunol 2000,
164(5):2311-2319.
51. Singh DK, Kumar D, Siddiqui Z, Basu SK, Kumar V, Rao KV: The strength of
receptor signaling is centrally controlled through a cooperative loop
between Ca2+ and an oxidant signal. Cell 2005, 121(2):281-293.
52. Benschop RJ, Brandl E, Chan AC, Cambier JC: Unique signaling properties
of B cell antigen receptor in mature and immature B cells: implications
for tolerance and activation. J Immunol 2001, 167(8):4172-4179.
53. Koncz G, Bodor C, Kovesdi D, Gati R, Sarmay G: BCR mediated signal
transduction in immature and mature B cells. Immunol Lett 2002, 82(1-
2):41-49.
54. Rolli V, Gallwitz M, Wossning T, Flemming A, Schamel WW, Zurn C, Reth M:
Amplification of B cell antigen receptor signaling by a Syk/ITAM positive
feedback loop. Mol Cell 2002, 10(5):1057-1069.
55. Liu Y, Kruhlak MJ, Hao JJ, Shaw S: Rapid T cell receptor-mediated SHP-1
S591 phosphorylation regulates SHP-1 cellular localization and
phosphatase activity. J Leukoc Biol 2007, 82(3):742-751.
56. Donjerkovic D, Scott DW: Activation-induced cell death in B lymphocytes.
Cell Res 2000, 10(3):179-192.
57. Parker DC: Induction and suppression of polyclonal antibody responses
by anti-Ig reagents and antigen-nonspecific helper factors: a comparison
of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells.
Immunol Rev 1980, 52:115-139.
58. Klaus GG, Hawrylowicz CM: Activation and proliferation signals in mouse
B cells. II. Evidence for activation (G0 to G1) signals differing in
sensitivity to cyclosporine. Eur J Immunol 1984, 14(3):250-254.
59. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA:
Involvement of stress-activated protein kinase and p38 mitogen-
activated protein kinase in mIgM-induced apoptosis of human B
lymphocytes. Proc Natl Acad Sci USA 1996, 93(24):13814-13818.
60. Carman JA, Wechsler-Reya RJ, Monroe JG: Immature stage B cells enter
but do not progress beyond the early G1 phase of the cell cycle in
response to antigen receptor signaling. J Immunol 1996,
156(12):4562-4569.
61. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR: Differential
activation of the ERK, JNK, and p38 mitogen-activated protein kinases
by CD40 and the B cell antigen receptor. J Immunol 1996,
157(8):3381-3390.
62. Baba Y, Hashimoto S, Matsushita M, Watanabe D, Kishimoto T, Kurosaki T,
Tsukada S: BLNK mediates Syk-dependent Btk activation. Proc Natl Acad
Sci USA 2001, 98(5):2582-2586.
63. Kurosaki T, Tsukada S: BLNK: connecting Syk and Btk to calcium signals.
Immunity 2000, 12(1):1-5.
64. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL,
Burgering BM: FOXO transcription factor activation by oxidative stress
mediated by the small GTPase Ral and JNK. Embo J 2004,
23(24):4802-4812.
doi:10.1186/1752-0509-4-169
Cite this article as: Jamal et al.: Defining the antigen receptor-
dependent regulatory network that induces arrest of cycling immature
B-lymphocytes. BMC Systems Biology 2010 4:169.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Jamal et al. BMC Systems Biology 2010, 4:169
http://www.biomedcentral.com/1752-0509/4/169
Page 21 of 21
